SUSAN BENNETT: Open Payments
NPI 1750799334 · WILLIAMSPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 11 payments from 9 companies in 2025. Trend: 2023 $493 · 2024 $746 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $226 |
| Astellas Pharma US Inc | 1 | $140 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $118 |
| Novocure Inc. | 1 | $96 |
| JAZZ PHARMACEUTICALS INC. | 1 | $20 |
Products named: Vyloy, REBLOZYL, ZYNLONTA, Orserdu, RYBREVANT, ENHERTU, OJJAARA, Optune Lua (NovoTTF-200T).
Industry payments across PA — which companies pay providers there.
